Navigation Links
Gastroenterologists Indicate They Are Increasingly Using Biologics to Treat Patients with Crohn's Disease in Remission than They Were One Year Ago, According to a Recent BioTrends Report
Date:3/5/2013

tmentTrends®: Crohn's Disease (US) report also reveals that three-quarters of the surveyed physicians feel that there is a high unmet need for new agents to treat Crohn's disease, often citing that they are challenged by the adverse events/side effects of current treatment and that achieving and maintaining remission and avoiding treatment failures are also issues. With regard to products in development, nearly one-third of gastroenterologists claim to be aware of products in development for the treatment of CD. Of those with unaided awareness of products in development, more than one-quarter noted Janssen's ustekinumab (Stelara), 22 percent specifically noted Takeda's vedolizumab and 22 percent noted Janssen's Simponi. When aided and asked which emerging agent will bring the most value to their practices, gastroenterologists are divided in opinion among vedolizumab, Stelara and Traficet-EN.

TreatmentTrends®: Crohn's Disease (US)  is an annual syndicated primary market research report series that provides a comprehensive view of the current and expected future management of CD, with a focus on biologic treatment. The survey was fielded in February.  The study included 91 board-certified gastroenterologists. TreatmentTrends®: Crohn's Disease (US) covers treatment approaches, including the use of pharmacotherapy for the treatment of CD, as well as attitudes and perceptions toward the biologic agents, advantages and disadvantages of these agents, ideal patient types, barriers to growth, and expected future use. In addition, respondents were queried about their awareness of and interest in products in development for the treatment of CD.About BioTrends Research Group'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Big Pharma and Universities Increasingly Work to Advance Life Science Knowledge by Forming Strategic Partnerships, Public-Private Partnerships, and Open Innovation Programs: Pharmaceutical Research Collaborations Summit
2. Probiotic Action Comments on New Findings on Using Light Therapy to Fight Acne
3. Is Stress Causing Breakouts? Probiotic Action Sheds Light on an Article by the Huffington Post on if Acne and Stress are Still Related
4. Modeling Alzheimers disease using iPSCs
5. Using 3-D printing and injectable molds, bioengineered ears look and act like the real thing
6. Probiotic Action Discusses Using Social Media to Teach the Public about Acne
7. Forging a new periodic table using nanostructures
8. Probiotic Action Exposes 4 Items You Didn't Know were Causing Breakouts
9. Using single quantum dots to probe nanowires
10. Rigku Publishes New Method for Quantitative Analysis of Cast Iron Using the ZSX Primus III+
11. PNNL awarded $2.8 million to keep troops cool while using less fuel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... -- GenomeDx Biosciences today announced that a new study ... test for prostate cancer, was able to predict rapid ... prostatectomy without adjuvant therapy. Although rapid metastasis in men ... genomics to identify these men who have a highly ... The study has been published online by the ...
(Date:12/22/2014)... The American Journal of Hematology/Oncology, a ... editorials addressing developments and pathways related to oncological ... article exploring the role of follicle-stimulating hormone (FSH) ... prostate cancer. , The article references seminal ... there could be a connection to prostate cancer ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... MA (PRWEB) December 19, 2014 Charm ... MRLAFMQ test for the Detection of Aflatoxin M1 in ... to receive independent third party validation. The peer reviewed ... Unit of the Institute for Agricultural and Fisheries Research ... Group. , Aflatoxin B1, the most toxic aflatoxin ...
Breaking Biology Technology:Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2
... May 5 Breakthrough biotechnology research is providing ... cognitive health and diabetes, two leading health concerns ... CEO of Advana Science, www.advanascience.com ... advancement of this dynamic consumer healthy category at ...
... from GlaxoSmithKlineMOUNTAIN VIEW, Calif., May 5 ChemoCentryx, ... orally bioavailable small molecule antagonist of the C5a ... The acceptance of the molecule as a ... from the alliance with GlaxoSmithKline (NYSE: ...
... FRANCISCO, Calif., May 5 Poniard Pharmaceuticals, Inc. (Nasdaq: ... Data Monitoring Committee (DMC), after review of available information ... recommends that the SPEAR (Study of Picoplatin Efficacy After ... is evaluating the efficacy and safety of picoplatin in ...
Cached Biology Technology:Industry Expert Reveals Cutting Edge Biotechnology Science for Nutraceutical and Functional Food Applications 2ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 2ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 3ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 4Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 2Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 3Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 4Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 5
(Date:12/17/2014)... 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend ... for medical sensors in biomedical applications. Chemical sensors ... and correct diagnosis during surgical procedures. The Global ...
(Date:12/11/2014)... 2014  That blood pressure plays a role in human ... the medical term for high blood pressure – was first ... inflatable cuff that,s used in measuring blood pressure was invented ... new about hypertension, its triggers and its effects. In fact, ... and the best ways to treat it. For ...
(Date:12/10/2014)... 2014 CIE San Diego has launched an ... connective tissue that enhances care coordination among social service ... client-level information; earned a second $1 million grant from ... seniors aging in community and; will be recognized as ... th 4-6p. CIE San Diego today ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... recent study led by scientists from the National University of ... Spinal Muscular Atrophy (SMA), a devastating disease that is the ... young adults. As there is currently no known cure for ... fight against SMA. SMA is caused by deficiencies ...
... , Dec. 18, 2013 Tissue engineering ... a regenerative or reparative medicine with potential to ... engineering, which involve leveraging technologies from biomaterials, molecular ... the restructure and/or repair of human organs through ...
... have shown for the first time that the specialised role ... cilia tiny hair-like structures protruding from a cell. Stem ... body through the process of differentiation. The discovery ... therapies for a range of medical treatments where scientists aim ...
Cached Biology News:Study led by NUS scientists provides new insights into cause of human neurodegenerative disease 2Study led by NUS scientists provides new insights into cause of human neurodegenerative disease 3State-of-the-Art Tissue Engineering and Organ Regeneration Technologies Yield Healthcare Market Disruption 2State-of-the-Art Tissue Engineering and Organ Regeneration Technologies Yield Healthcare Market Disruption 3State-of-the-Art Tissue Engineering and Organ Regeneration Technologies Yield Healthcare Market Disruption 4
Lysozyme C (W-20)...
... BR4i refrigerated multifunction centrifuges are equally capable of ... low sound level with a large range of ... rotor exchange system without tools ensures that the ... Instant rotor exchange (5 sec.) ...
... (5-bromo-4-chloro-3-indoyl-beta-D-galactopyranoside) is a chromogenic ... recombinant plasmids. In the ... IPTG, lac + ... whereas recombinant colonies appear ...
... AcTEV Protease is an enhanced form of ... highly site-specific, highly active, and significantly more ... long-term activity. AcTEV Protease specifically recognizes a ... and Gly), making it useful for removing ...
Biology Products: